Nalgesin Pro (Naproxen Sodium)

Naproxen sodium, the active ingredient in Nalgesin Pro, is a nonsteroidal anti-inflammatory drug presented as an oral formulation for systemic use. It is used to relieve mild to moderate pain, reduce inflammation in conditions such as osteoarthritis and rheumatoid arthritis, and lower fever in adult patients.

GNH USA supplies Nalgesin Pro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable sourcing for global healthcare providers through.

Naproxen sodium is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes.

- Mild to moderate pain: Provides analgesic relief for conditions such as headache, dental pain, or musculoskeletal discomfort. - Osteoarthritis and rheumatoid arthritis: Decreases joint inflammation and improves mobility. - Dysmenorrhea: Relieves menstrual cramps and associated pelvic pain. - Fever: Lowers elevated body temperature in acute febrile states.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: Dyspepsia, abdominal pain, or heartburn. - Nausea and vomiting: Transient episodes after oral intake. - Headache: Mild to moderate intensity. - Dizziness or vertigo: May affect balance. - Skin rash: Mild erythema or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: Can be life‑threatening. - Cardiovascular events: Increased risk of myocardial infarction or stroke. - Renal impairment: Acute kidney injury, especially in dehydrated patients. - Hepatic enzyme elevation: Potential liver function abnormalities. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: Rare but requires immediate medical attention.

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately.

- Assess gastrointestinal risk: Review history of ulcers, bleeding disorders, or chronic NSAID use. - Evaluate cardiovascular status: Use cautiously in patients with hypertension, heart disease, or stroke risk. - Monitor renal function: Check serum creatinine and electrolytes in those with kidney disease or dehydration. - Check hepatic health: Perform liver function tests if pre‑existing liver disease is present. - Use the lowest effective dose: Limit duration to the shortest period needed for symptom control. - Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Naproxen sodium can alter the pharmacodynamics or pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): Increased risk of serious bleeding. - Other NSAIDs or aspirin: Heightened gastrointestinal toxicity. - Corticosteroids: Synergistic ulcerogenic effect. - Lithium: Reduced renal clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): May modestly raise bleeding risk. - Diuretics and antihypertensives: Potential reduction in antihypertensive efficacy. - Methotrexate: Decreased renal elimination, raising toxicity potential.